Objective: This study was conducted to determine the incremental healthcare resource utilization (HRU) and costs associated with relapse or recurrence (R/R) in patients with major depressive disord...
CITATION STYLE
Gauthier, G., Mucha, L., Shi, S., & Guerin, A. (2019). Economic burden of relapse/recurrence in patients with major depressive disorder. Journal of Drug Assessment, 8(1), 97–103. https://doi.org/10.1080/21556660.2019.1612410
Mendeley helps you to discover research relevant for your work.